insider buying

insider buying Articles

Has BlackRock CEO Larry Fink been increasing or decreasing his share count over the past year? Does he know something we don’t?
Has Freshworks CEO Girish Mathrubootham been increasing or decreasing his share count over the past year? Does he know something we don’t?
As January wound to a close, beneficial owners, executives, and other insiders took advantage of public offerings of stock at these biotech companies.
Has NerdWallet CEO Tim Chen been increasing or decreasing his share count over the past year? Does he know something we don’t?
Has Trade Desk CEO Jeffrey Green been increasing or decreasing his shares over the past year? Does he know something we don’t?
Has Prospect Capital CEO John Barry been increasing or decreasing his share count over the past year? Does he know something we don’t?
Recent insider buying has been highlighted by purchases by Warren Buffett, Jack Ma, Carlos Slim, and John Paulson. Biotechs tempted insiders, as did public offerings.
Insider buying was somewhat slow in the middle of January, but some purchases by Warren Buffett's Berkshire Hathaway made headlines.
As the year got underway, biotechs were in focus among the notable insider buying, especially in two companies focused on treatments for the eye.
As the year wound to a close, the most notable insider buying was focused on biotech stocks, but an oil and gas company CEO also returned to the buy window.
Warren Buffett's Berkshire Hathaway has again bolstered its stake in Occidental Petroleum, and action at Dollar Tree also highlights recent insider buying.
Warren Buffett's Berkshire Hathaway has bolstered its stake in Occidental Petroleum with a huge purchase of shares. Insider buying is heating up in general.
A biotech stock rallying on encouraging trial results prompted insider buying and selling. A specialty retailer and others saw insider buying too.
Some of the biggest insider buying since the Thanksgiving holiday has come from repeat buyers, including Bill Ackman, who continues to build his stake in a real estate firm.
Notable insider buying in the past week included biotech and energy companies, including some that have just gone public. Also, renowned hedge fund manager Bill Ackman continues building a stake in a...